Literature DB >> 31567270

Undiagnosed Systemic Mastocytosis Presenting as Postoperative Distributive Shock: A Case Report.

Juan G Ripoll1, Matthew J Ritter1,2,3, Thomas B Comfere1,2, Mark M Smith1,3, Hartzell V Schaff4, George D Gilkey1,3, Matthew A Warner1,2.   

Abstract

Systemic mastocytosis (SM) is a rare clinical condition resulting from a clonal proliferation of abnormal mast cells. The clinical presentation may vary from mild cutaneous manifestations to aggressive systemic symptoms including intermittent episodes of anaphylaxis. We present a case of a 69-year-old male with abrupt and recurrent episodes of anaphylaxis with refractory distributive shock following cardiac surgery with cardiopulmonary bypass. Following a complex postoperative course, a bone marrow biopsy ultimately confirmed the diagnosis. Although rare, SM should be considered in the differential diagnosis of postoperative patients with unexplained and recurrent episodes of distributive shock.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31567270      PMCID: PMC6856421          DOI: 10.1213/XAA.0000000000001093

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  11 in total

Review 1.  Vasoplegia during cardiac surgery: current concepts and management.

Authors:  Gregory W Fischer; Mathew A Levin
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

2.  Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.

Authors:  Ken-Hong Lim; Ayalew Tefferi; Terra L Lasho; Christy Finke; Mrinal Patnaik; Joseph H Butterfield; Rebecca F McClure; Chin-Yang Li; Animesh Pardanani
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

3.  Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.

Authors:  Animesh Pardanani
Journal:  Am J Hematol       Date:  2019-01-02       Impact factor: 10.047

Review 4.  Drug allergy in mastocytosis.

Authors:  Patrizia Bonadonna; Carla Lombardo
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-13       Impact factor: 3.479

5.  Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption.

Authors:  V A Thomas; C J Wheeless; M S Stack; D A Johnson
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

Review 6.  How we diagnose and treat systemic mastocytosis in adults.

Authors:  Robyn M Scherber; Uma Borate
Journal:  Br J Haematol       Date:  2017-10-19       Impact factor: 6.998

Review 7.  Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Gunnar Nilsson; Andreas Reiter; Olivier Hermine; Karl Sotlar; Wolfgang R Sperr; Luis Escribano; Tracy I George; Hanneke C Kluin-Nelemans; Celalettin Ustun; Massimo Triggiani; Knut Brockow; Jason Gotlib; Alberto Orfao; Lawrence B Schwartz; Sigurd Broesby-Olsen; Carsten Bindslev-Jensen; Petri T Kovanen; Stephen J Galli; K Frank Austen; Daniel A Arber; Hans-Peter Horny; Michel Arock; Dean D Metcalfe
Journal:  Cancer Res       Date:  2017-03-02       Impact factor: 12.701

8.  Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.

Authors:  Christoph Sucker; Georg Mansmann; Stefan Steiner; Norbert Gattermann; Anette Schmitt-Graeff; Robert Loncar; Rudiger E Scharf; Marcus Stockschlader
Journal:  Clin Appl Thromb Hemost       Date:  2007-12-26       Impact factor: 2.389

Review 9.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

10.  Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.

Authors:  S E Kimmel; M A Sekeres; J A Berlin; N Ellison; V J DiSesa; B L Strom
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.